DRG Market Assessment reports

Clarivate Epidemiology’s coverage of diabetic macular edema (DME) comprises epidemiological estimates of key patient populations in 45 countries. We report the prevalence of DME for each country…

characterized by alterations in motility, stool consistency and frequency, and urgency. It is generally classified into three subtypes: constipation  predominant, diarrhea predominant, and mixed…

Clarivate Epidemiology’s coverage of benign prostatic hyperplasia comprises epidemiological estimates of key patient populations across 45 countries worldwide. We report the prevalence of benign…

Clarivate Epidemiology’s coverage of benign prostatic hyperplasia comprises epidemiological estimates of key patient populations across 45 countries worldwide. We report the prevalence of benign…

Clarivate Epidemiology’s coverage of BPH comprises epidemiological estimates of key patient populations across 45 countries worldwide. We report the prevalence of BPH for each country, as well as…

Clarivate Epidemiology’s coverage of male hypogonadism comprises epidemiological estimates of key patient populations in the major mature pharmaceutical markets (the United States, France,…

Clarivate’s Extrapolated Worldwide Coverage is the first and only evidence-based data set of epidemiological forecasts for key BPH patient populations covering 171 countries and more than 99% of…

Clarivate Epidemiology’s coverage of male lower urinary tract symptoms (LUTS) comprises epidemiological estimates of key patient populations in 45 countries worldwide. We report the prevalence of…

Clarivate Epidemiology’s coverage of male lower urinary tract symptoms (LUTS) comprises epidemiological estimates of key patient populations in 45 countries worldwide. We report the prevalence of…

Clarivate Epidemiology’s coverage of male lower urinary tract symptoms (LUTS) comprises epidemiological estimates of key patient populations in 45 countries worldwide. We report the prevalence of…

Clarivate Epidemiology’s coverage of male lower urinary tract symptoms (LUTS) comprises epidemiological estimates of key patient populations in 45 countries worldwide. We report the prevalence of…

Clarivate Epidemiology’s coverage of male lower urinary tract symptoms (LUTS) comprises epidemiological estimates of key patient populations in 45 countries worldwide. We report the prevalence of…